Alan Greenspan dies at 100; The central banker whose words moved global markets - Remembering former US Fed Chair - Markets

Alan Greenspan dies at 100; The central banker whose words moved global markets – Remembering former US Fed Chair – Markets

Alan Greenspan Dies at 100: Former US Federal Reserve Chair Alan Greenspan died Monday from complications of Parkinson’s disease, said his wife of 29 years, NBC News correspondent Andrea Mitchell. He was 100. “To me he was my husband, who shaped my life from our very first date in 1984,” Mitchell said. “He had ‘irrational…

Read More
Investment Strategy at 50: Lump Sum or SIP? 9 funds recommended by expert to plan smart and balance risk - Mutual Funds

Stock to Sell Today: HDFC Securities cautious on Nykaa – 5 reasons why – Markets

Stock to Sell Today: HDFC Securities cautious on Nykaa – 5 reasons why (Image: Canva/ET Now Digital) Stock to Sell Today: FSN E-Commerce Ventures Limited, popularly known as Nykaa, is a prominent Indian consumer technology platform. It is one of the market leaders in content-led, lifestyle retail. The company operates primarily through Nykaa Beauty and…

Read More
Investment Strategy at 50: Lump Sum or SIP? 9 funds recommended by expert to plan smart and balance risk - Mutual Funds

Aurobindo Pharma Share In Focus: Nuvama hikes target for pharma stock after $250 mn Lannett buyout nod – Key reasons to Buy – Markets

Aurobindo Pharma Share In Focus: Nuvama hikes target for pharma stock after $250 mn Lannett buyout nod – Key reasons to Buy (Image source: Shutterstock/ET NOW) Aurobindo Pharma Share Price Target 2026: Brokerage firm Nuvama has delivered a bullish outlook on Aurobindo Pharma’s stock after the company said its arm Aurobindo Pharma USA, Inc had…

Read More
Sensex, Nifty 50 Today | Stock Market LIVE, 23 June 2026: Sensex & Nifty Today, Share Price Action and Sector Performance

Sensex, Nifty 50 Today | Stock Market LIVE, 23 June 2026: Sensex & Nifty Today, Share Price Action and Sector Performance

In the previous trading session, Cipla Ltd surged to a closing price of 1415.7, marking a strong gain of 4.73%. Tech Mahindra Ltd advanced 1.82% to close at 1435.2, while Dr Reddys Laboratories Ltd increased by 1.46% to 1290.7. Sun Pharmaceutical Industries Ltd and Infosys Ltd also saw gains, closing at 1862.9 and 1065.4, respectively….

Read More
Top Stocks to BUY, SELL or HOLD Today: Nykaa, ​Ather Energy, Aurobindo Pharma, Meesho and others - Markets

Top Stocks to BUY, SELL or HOLD Today: Nykaa, ​Ather Energy, Aurobindo Pharma, Meesho and others – Markets

Top Stocks to BUY, SELL or HOLD Today, June 23: Brokerage firms issued fresh stock recommendations on several Indian companies, with buy calls on Aurobindo Pharma, Persistent Systems, Mahindra Logistics, Ather Energy and Stovekraft, while HDFC Securities retained a sell rating on Nykaa. Citi also initiated coverage on Meesho with a buy rating and outlined…

Read More
Meesho share price in focus as Citi initiates ‘Buy’, sees nearly 23% upside - Check target price - Markets

Meesho share price in focus as Citi initiates ‘Buy’, sees nearly 23% upside – Check target price – Markets

Meesho is likely to be in focus after Citi initiated coverage on the value-focused e-commerce platform with a ‘buy’ rating, setting a target price of Rs 210 and indicating an upside potential of nearly 23 per cent from current levels. The brokerage remains optimistic on the company’s strong growth trajectory, backed by its expanding user…

Read More
EV Stock to BUY: Brokerage sees 20% upside for this electric 2-wheeler stock on EV adoption wave - DETAILS - Markets

EV Stock to BUY: Brokerage sees 20% upside for this electric 2-wheeler stock on EV adoption wave – DETAILS – Markets

EV Stock to BUY: As electric vehicles continue to gain momentum, electric two-wheeler manufacturer Ather Energy remains in focus in the stock market. Brokerage firm Emkay has turned bullish on the stock, maintaining a “BUY” rating and highlighting that the E-2W (electric two-wheeler) segment is at an inflexion point. Ather Energy Share Price Target 2026Emkay…

Read More
Citi flags FY27 pain for cement sector; Ultratech, JSW Cement top picks as Grasim, Shree, Dalmia earn ‘Buy’ calls, Ramco gets ‘Sell’ tag - Markets

Citi flags FY27 pain for cement sector; Ultratech, JSW Cement top picks as Grasim, Shree, Dalmia earn ‘Buy’ calls, Ramco gets ‘Sell’ tag – Markets

Citi has sounded a note of caution on India’s cement sector, warning that FY27 could prove to be a challenging year amid weak pricing trends, declining profitability metrics, and demand headwinds linked to slower government spending and a potentially weak monsoon. While the brokerage sees near-term pressure on utilization levels and margins, it remains constructive…

Read More